SOC Telemed (SOC Telemed) Risk Assessment

View and export this data going back to 2020. Start your Free Trial

What is SOC Telemed Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of SOC Telemed is: No Data: Cannot be evaluated.

Competitive Comparison of SOC Telemed's Risk Assessment

For the Medical Care Facilities subindustry, SOC Telemed's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SOC Telemed's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, SOC Telemed's Risk Assessment distribution charts can be found below:

* The bar in red indicates where SOC Telemed's Risk Assessment falls into.

SOC Telemed (NAS:TLMD) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

SOC Telemed Risk Assessment Related Terms

Thank you for viewing the detailed overview of SOC Telemed's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

SOC Telemed (SOC Telemed) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SOC Telemed Inc (NAS:TLMD) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

1768 Business Center Drive, Suite 100, Reston, VA, USA, 20190

Website

https://www.soctelemed.com

SOC Telemed Inc is a provider of acute care telemedicine services and technology to U.S. hospitals and healthcare systems based on number of clients. It provides technology enabled clinical solutions which include acute teleNeurology, telePsychiatry, and teleICU, and telePulmonology service. It supports specialty care, providing time-sensitive specialty care when patients are vulnerable and may not otherwise have access. Its solution was developed to support complex workflows in the acute care setting by integrating cloud-based software platform, Telemed IQ, with a panel of patient advocates and a network of clinical specialists to create a seamless, acute telemedicine solution.

Executives

Robert Jason Hallock	officer: Chief Medical Officer	C/O SOC TELEMED 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
David R. Fletcher	officer: Interim CFO	C/O SOC TELEMED, INC., 1768 BUSINESS CENTER DRIVE, SUITE 100, RESTON VA 20190
David Mikula	officer: Chief Operating Officer	C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Gyasi C. Chisley	director	C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Christopher M. Gallagher	director	C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Steven J Shulman	director	1564 NE EXPRESSWAY, ATTN: BJ PURCELL, ATLANTA GA 30329
Christopher K Knibb	officer: Chief Financial Officer	C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Warburg Pincus Partners Ii, L.p.	director, 10 percent owner	450 LEXINGTON AVENUE, C/O WARBURG PINCUS LLC, NEW YORK NY 10017
Anne Mcgeorge	director	C/O MAGENTA THERAPEUTICS, INC., 100 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE MA 02139
Wpxi Finance, Lp	director, 10 percent owner	C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017
Wpxi Gp, L.p.	director, 10 percent owner	C/O WARBURG PINCUS LLC, 450 LEXINGTON AVE, NEW YORK NY 10017
Warburg Pincus & Co.	director, 10 percent owner	450 LEXINGTON AVENUE, NEW YORK, NY NY 100173147
Amr Kronfol	director	C/O WARBURG PINCUS LLC, 450 LEXINGTON AVE, NEW YORK NY 10017
Joseph P Greskoviak	director	C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Sean Banerjee	officer: Chief Technology Officer	C/O SOC TELEMED 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190